Home › Acute Lung Injury › California
Pag-aaral pangklinika para sa Acute Lung Injury sa California
6 pag-aaral para sa Acute Lung Injury ang naghahanap ng mga kalahok sa mga site sa California.
Mga Lungsod sa California
- Mountain View5 pag-aaral
- Long Beach4 pag-aaral
- Fresno4 pag-aaral
- Sacramento4 pag-aaral
- Orange4 pag-aaral
Opisyal na teksto ng pag-aaral (English)
Belumosudil to Block Chronic Lung Allograft Dysfunction (CLAD) in High Risk Lung Transplant Recipients
- University of California, Los Angeles (Site #: 71123), Los Angeles
- Stanford University (Site #: 71141), Palo Alto
Nagre-recruitPhase 2
Edad 12 pataas · Lahat ng kasarian · Na-update Ago 10, 2026 · NCT06476132JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS- Cohort B: Paridiprubart
- Community Regional Medical Center, Fresno
- Long Beach Memorial Medical Center, Long Beach
- University of California Irvine Medical Center, Orange
- at 2 pa
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Hul 31, 2026 · NCT06701669JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS- Cohort A: Vilobelimab
- Community Regional Medical Center, Fresno
- Long Beach Memorial Medical Center, Long Beach
- University of California Irvine Medical Center, Orange
- at 2 pa
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Hul 31, 2026 · NCT06701682JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS- Cohort C: Bevacizumab
- Community Regional Medical Center, Fresno
- Long Beach Memorial Medical Center, Long Beach
- University of California Irvine Medical Center, Orange
- at 2 pa
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Hul 31, 2026 · NCT06701656JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS (Master Record)
- Community Regional Medical Center, Fresno
- Long Beach Memorial Medical Center, Long Beach
- University of California Irvine Medical Center, Orange
- at 2 pa
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Hul 31, 2026 · NCT06703073This Study is Assessing the Safety and Efficacy of Immune Inhibition as a Treatment to Prevent Primary Graft Dysfunction
- University of California, San Francisco, San Francisco
Nagre-recruitPhase 2Malugod na tinatanggap ang malusog na boluntaryo
Edad 18 pataas · Lahat ng kasarian · Na-update Ene 20, 2026 · NCT06853223Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.